Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 Signaling
Styliani Karanika(Johns Hopkins University), Timothy C. Thompson(The University of Texas MD Anderson Cancer Center), Nora M. Navone(The University of Texas MD Anderson Cancer Center), Patricia Troncoso(The University of Texas MD Anderson Cancer Center), Theodoros Karantanos(Johns Hopkins University), Paul G. Corn(Cornell University), Guang Yang(Jinan University), Ganiraju C. Manyam(The University of Texas MD Anderson Cancer Center), Sankar N. Maity(The University of Texas MD Anderson Cancer Center), Jianxiang Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Shuhua Li(Chinese Academy of Sciences), Sanghee Park(Hanbat National University), Xuemei Zuo(The University of Texas MD Anderson Cancer Center), Jian H. Song(The University of Texas MD Anderson Cancer Center), Likun Li(The University of Texas MD Anderson Cancer Center), Yaoguang Zhang(Beijing United Family Hospital), Bradley M. Broom(The University of Texas MD Anderson Cancer Center), Gary E. Gallick(The University of Texas MD Anderson Cancer Center), Ana M. Aparicio(The University of Texas MD Anderson Cancer Center)
Cited by 107
Related Papers
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
The Molecular Taxonomy of Primary Prostate Cancer
|Cell|2015|3.3k